Treatment of Depression in Pregnancy

Depression during pregnancy (antenatal or prenatal depression) affects approximately 10-20% of pregnant women. If you’re experiencing depression during pregnancy, it’s important to know that you are not alone, and effective treatments are available.

This article addresses three common situations:

• If you’re already taking antidepressants and wondering about continuing during pregnancy
• If you’re experiencing new or recurring depression during pregnancy
• If you’re having depressive symptoms and unsure if they warrant treatment

Understanding the Two Exposures: Depression and Treatment

When addressing depression during pregnancy, it’s important to understand that there are two potential exposures to consider:

1. Depression itself: Untreated depression can affect both your wellbeing and pregnancy outcomes
2. Treatment approaches: Some treatments, particularly certain medications, have potential effects on pregnancy

The goal of treatment is not to minimize one exposure at the expense of increasing the other, but rather to find the most effective approach for your specific situation that addresses your symptoms while considering pregnancy factors.

The Impact of Untreated Depression

Depression during pregnancy is not just a matter of mood—it can have significant effects on both parent and baby:

• Increased risks of preterm birth and low birth weight
• Higher rates of pregnancy complications
• Reduced adherence to prenatal care
• Greater likelihood of postpartum depression
• Potential impacts on infant development and bonding

Research consistently shows that these risks are real and significant. Even milder symptoms that don’t meet the full criteria for clinical depression can, if persistent, affect wellbeing and pregnancy outcomes.

For Those With Mild Symptoms

If you’re experiencing mild symptoms and wondering if they warrant treatment, consider:

1. Are your symptoms persistent? Even mild symptoms that persist for two weeks or more deserve attention.
2. Are your symptoms affecting your functioning? Consider impacts on sleep, appetite, energy, concentration, and ability to engage in daily activities.
3. Have you had depression previously? Those with a history of depression are at higher risk for recurrence during pregnancy.

Even if your symptoms are mild, proactive intervention with approaches like mindfulness, regular physical activity, and enhanced social support can prevent worsening of symptoms. These approaches have benefits beyond mood improvement and virtually no downsides.

When to Seek Help Immediately

While many treatment approaches can be planned and implemented gradually, certain situations require immediate attention:

• Thoughts of harming yourself
• Inability to meet basic needs (eating, sleeping)
• Inability to sleep (beyond typical pregnancy sleeping difficulties) as this is a serious risk factor for suicidality
• Symptoms that prevent daily functioning
• Psychotic symptoms (hallucinations, delusions)

If you experience any of these, contact your healthcare provider immediately or go to your local emergency department.

Creating a Comprehensive Treatment Plan

The most effective approach to managing depression during pregnancy is a comprehensive treatment plan tailored to your specific needs. Every treatment plan should include these essential elements:

1. Medication consideration: Even if you decide not to use medication now, discussing this option with your healthcare provider is an important part of creating a complete treatment plan. The decision should be based on symptom severity, prior history, and individual circumstances, and can be revisited as needed.
2. Evidence-based non-medication treatments: Incorporate proven therapies such as CBT, IPT, ACT, or mindfulness-based approaches based on what works best for you and what’s available.
3. Regular assessment and monitoring: Using structured tools to track symptoms helps determine if adjustments to your treatment plan are needed. Our app’s wellbeing check-ins can assist with regular symptom monitoring.
4. Lifestyle components:
   • Sleep hygiene strategies
   • Nutritious, regular meals
   • Appropriate physical activity
   • Stress management techniques

1. Social support enhancement: Identify and strengthen connections with supportive people in your life, consider joining pregnancy or mental health support groups, and communicate your needs to partners and family.
2. Postpartum planning: Develop a specific plan for the postpartum period, including support systems, continuation of treatment, and warning signs that might indicate a need for additional help.

For many people, a combination of approaches—such as medication plus psychotherapy—provides more significant benefit than either approach alone. Research consistently shows that combinations of treatments often work better than single treatments for depression.

Depression and anxiety frequently co-occur, with many patients experiencing both conditions simultaneously; see Treatment of General & Medical Anxiety in Pregnancy for more information

For Those Already Taking Antidepressants

If you’re already taking antidepressants and discover you’re pregnant, don’t stop your medication abruptly without talking to your doctor. Doing so can lead to:

• Withdrawal symptoms
• High risk of depression relapse (studies show 50-85% relapse rate when stopping)
• Increased stress during early pregnancy

Instead:

• Contact your healthcare provider right away to discuss risks and benefits of medication in pregnancy. 
• If you are unable to have a discussion with your provider in a timely manner ,you can learn more about the risks and benefits of different medications both in this article and by searching your specific medication in Obi. If your medication is not covered here you can text MothertoBaby at 1(855)999-3525 with your medication question.
• Work with your provider to evaluate your current treatment and determine if any adjustments are needed

Studies show that for many people, continuing effective treatment throughout pregnancy results in better outcomes than discontinuing medication.

For Those Experiencing New or Recurring Depression

If you’ve developed depression during pregnancy or experiencing a recurrence of previously treated depression, several treatment options are available:

Medication Options and Considerations

The goal of medication treatment is to find the effective dose that adequately treats your symptoms. There is no evidence that lower doses of antidepressants pose less risk to the baby, and inadequately treated depression exposes both you and your baby to the risks of the illness.

Here’s what research tells us about commonly used antidepressants:

Selective Serotonin Reuptake Inhibitors (SSRIs)

SSRIs are the most widely studied and prescribed antidepressants during pregnancy.

Sertraline (Zoloft):

• Often considered a first-line option when starting treatment during pregnancy
• Minimal transfer across the placenta compared to some other SSRIs
• Extensive safety data available with no consistent pattern of major birth defects
• Can be continued during breastfeeding after birth if needed

Fluoxetine (Prozac):

• Longer half-life means it stays in the system longer
• Well-studied with no consistent pattern of birth defects
• Can be continued during breastfeeding but may accumulate in breastfed infants due to long half-life

Citalopram (Celexa) and Escitalopram (Lexapro):

• Generally considered reasonable options during pregnancy
• No consistent pattern of birth defects in large studies
• Can be continued during breastfeeding after delivery

Paroxetine (Paxil):

• Some studies suggest a small increased risk of cardiac defects, although this finding is inconsistent
• Generally not initiated during pregnancy, but may be continued if it’s been effective for you
• If you’re stable on paroxetine before pregnancy, the risk of switching may outweigh potential concerns
• Can be continued while breastfeeding if needed after delivery

Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)

Venlafaxine (Effexor) and Duloxetine (Cymbalta):

• Less pregnancy data than for SSRIs, but no consistent pattern of birth defects
• Can be appropriate choices, especially for those who have responded well to them previously
• Can generally be continued during breastfeeding after birth

Other Antidepressants

Bupropion (Wellbutrin):

• Alternative with different mechanism of action
• No consistent pattern of birth defects
• May be particularly helpful for those with fatigue or concentration difficulties
• Compatible with breastfeeding after delivery

Mirtazapine (Remeron):

• Limited pregnancy data but no clear pattern of increased risks
• May be helpful for those with significant sleep or appetite disturbances
• Can be continued during breastfeeding if needed postpartum

Understanding the Risks: Beyond Birth Defects

When considering medication, it’s important to understand all potential risks in context. Here are the key considerations with absolute risk numbers where available:

Birth Defects:

• The background rate of major birth defects in the general population is about 3% (3 per 100 births)
• Most studies of SSRIs show either no increased risk or a very small increase in absolute risk
• For example, if a small risk increase exists with paroxetine and cardiac defects, studies suggest the absolute risk might increase from about 1% to 1.5-2% (1-2 per 100 births)

Persistent Pulmonary Hypertension of the Newborn (PPHN):

• PPHN is a rare but serious condition affecting a newborn’s breathing
• Background rate in the general population is about 1-2 per 1,000 births (0.1-0.2%)
• SSRI use in late pregnancy may increase the absolute risk to approximately 3-6 per 1,000 births (0.3-0.6%)
• This represents a modest absolute risk increase, though the relative risk sounds larger

Neonatal Adaptation Syndrome:

• Up to 30% of infants exposed to SSRIs near delivery may experience temporary symptoms including jitteriness, irritability, mild respiratory distress, or feeding difficulties
• These symptoms are typically mild and resolve within two weeks with supportive care
• Some babies with neonatal adaptation syndrome require admission to the NICU for supportive care

Preterm Birth:

• The background rate of preterm birth is about 10% in the general population
• Research shows that untreated depression itself increases preterm birth risk
• Importantly, when comparing people with depression who take SSRIs to those with untreated depression, those receiving treatment actually have lower rates of preterm birth
• This suggests that effective treatment of depression may help reduce this risk rather than increase it

Developmental Effects:

• Multiple large studies show no significant impact on cognitive, behavioral, or emotional development in children exposed to antidepressants prenatally
• Any subtle effects that might exist are far outweighed by the known negative impacts of untreated maternal depression

Non-Medication Approaches

Whether used alongside medication or as stand-alone treatments, evidence-based non-medication approaches are essential components of depression treatment:

Psychotherapy Options

Cognitive Behavioral Therapy (CBT):

• Consistently shown to be effective for depression during pregnancy
• Focuses on identifying and changing negative thought patterns and behaviors
• Typically involves 12-16 weekly sessions
• Can be delivered individually or in groups, in-person or via telehealth
• Works effectively as a standalone treatment and shows enhanced effectiveness when combined with medication when appropriate

Interpersonal Therapy (IPT):

• Can be specifically adapted for pregnancy and the perinatal period
• Addresses relationship issues, role transitions, and life changes
• Particularly helpful for pregnancy-related stressors and relationship challenges

Acceptance and Commitment Therapy (ACT):

• Growing evidence supports its effectiveness for depression during pregnancy
• Focuses on accepting difficult thoughts and feelings rather than struggling with them
• Emphasizes clarifying personal values and taking action aligned with those values
• Particularly helpful for managing pregnancy-specific anxieties and adjusting to changing body and life circumstances
• Combines mindfulness skills with concrete behavior change strategies

Mindfulness as Depression Treatment

Mindfulness has emerged as a particularly effective approach for managing depression during pregnancy:

• Strong evidence base: A 2023 systematic review and network meta-analysis found mindfulness therapy was one of the most effective non-pharmacological treatments for both depression and anxiety during pregnancy
• Stress reduction mechanism: Mindfulness works by helping you observe thoughts and feelings without judgment, reducing the stress response and breaking cycles of rumination
• Neurological benefits: Research shows mindfulness practices can change brain activity in regions associated with depression and anxiety
• Compatible with other treatments: Can be effectively combined with medication or therapy

Our app’s WellBeing section offers bite-sized mindfulness practices designed for people with busy, full lives who want practices that integrate into what they’re already doing, rather than adding additional work. These practices can be particularly valuable during pregnancy when energy and time may be limited.

Additionally, our app provides regular wellbeing check-ins that screen for depression and anxiety during pregnancy and postpartum, helping you track your mental health and identify when additional support might be needed.

Physical Activity

Regular, moderate physical activity has been shown to help with depression symptoms. During pregnancy, consider:

• Walking (even short walks can help)
• Swimming or water exercises
• Prenatal yoga or gentle stretching
• Any movement that feels good to your body

Other Evidence-Based Approaches

Bright Light Therapy:

• Exposure to a special light box for 30 minutes daily
• Particularly helpful for depression with seasonal patterns
• Safe during pregnancy with proper equipment

Social Support Enhancement:

• Peer support groups specifically for pregnant women with depression
• Partner involvement in treatment
• Community resources and connection

Final Thoughts

Depression during pregnancy is common and treatable. With appropriate care, the vast majority of people experience significant improvement in symptoms.

Remember that treating depression effectively is beneficial for both you and your baby—they are not competing concerns. The healthiest pregnancy environment comes from addressing your mental health needs with evidence-based approaches.

Whether your path includes medication, therapy, lifestyle changes, or a combination of these, each step toward managing depression is valuable. You deserve support, and seeking help demonstrates your commitment to your wellbeing and that of your baby.

Sources

Dennis CL, Falah-Hassani K, Shiri R. Prevalence of antenatal and postnatal anxiety: systematic review and meta-analysis. British Journal of Psychiatry.

Woody CA, Ferrari AJ, Siskind DJ, et al. A systematic review and meta-regression of the prevalence and incidence of perinatal depression. Journal of Affective Disorders.

McAllister-Williams RH, Baldwin DS, Cantwell R, et al. British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum 2017. Journal of Psychopharmacology.

Yonkers KA, Wisner KL, Stewart DE, et al. The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. General Hospital Psychiatry.

Zeng G, Niu J, Zhu K, et al. Effects of non-pharmacological interventions on depressive and anxiety symptoms in pregnant women: a systematic review and network meta-analysis. eClinicalMedicine.

Grigoriadis S, VonderPorten EH, Mamisashvili L, et al. The impact of maternal depression during pregnancy on perinatal outcomes: a systematic review and meta-analysis. Journal of Clinical Psychiatry.

Cohen LS, Altshuler LL, Harlow BL, et al. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA.

Huybrechts KF, Palmsten K, Avorn J, et al. Antidepressant use in pregnancy and the risk of cardiac defects. New England Journal of Medicine.

Grigoriadis S, Vonderporten EH, Mamisashvili L, et al. Prenatal exposure to antidepressants and persistent pulmonary hypertension of the newborn: systematic review and meta-analysis of observational studies. BMJ.

Kieviet N, Dolman KM, Honig A. The use of psychotropic medication during pregnancy: how about the newborn? Neuropsychiatric Disease and Treatment.

Li X, Laplante DP, Paquin V, et al. Effectiveness of cognitive behavioral therapy for perinatal maternal depression, anxiety and stress: a systematic review and meta-analysis of randomized controlled trials. Clinical Psychology Review.

Hantsoo L, Ward-O’Brien D, Czarkowski KA, et al. A randomized, placebo-controlled, double-blind trial of sertraline for postpartum depression. Psychopharmacology.

Shortis E, Warrington D, Whittaker P. The efficacy of cognitive behavioral therapy for the treatment of antenatal depression: a systematic review. Journal of Affective Disorders.

ACOG Committee Opinion No. 757: Screening for Perinatal Depression. Obstetrics and Gynecology.

National Institute for Health and Care Excellence (NICE). Antenatal and postnatal mental health: clinical management and service guidance. NICE clinical guideline 192.